GLP1R-targeting drugs will continue to see demand due to pleiotropic benefits: Experts, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Despite the unavailability of Ozempic and Wegovy in India, the queries on the use and availability of the diabetes treatment drug continue to pour in on a daily basis for medical practitioners., Despite the unavailability of Ozempic and Wegovy in India, the queries on the use and availability of the diabetes treatment drug continue to pour in on a daily basis for medical practitioners., , Read More